Evidence map›Paper›PMID 34945083›Full record

ArticleJournal of clinical medicine2021

Macular Hemorrhage Due to Age-Related Macular Degeneration or Retinal Arterial Macroaneurysm: Predictive Factors of Surgical Outcome.

Mitta Pierre, Adam Mainguy, Irini Chatziralli, Kaivon Pakzad-Vaezi, Jorge Ruiz-Medrano, Bahram Bodaghi, Anat Loewenstein, Jayakrishna Ambati, Marc D de Smet, Ramin Tadayoni and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 7 countries.

Mitta PierreDepartment of Ophthalmology, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010 Paris, France.ORCID 0000-0002-6475-7657
Adam MainguyDepartment of Ophthalmology, Pitié Salpêtrière University Hospital, Sorbonne Université, 75013 Paris, France.ORCID 0000-0003-0871-7834
Irini Chatziralli2nd Department of Ophthalmology, National and Kapodistrian University of Athens, 10679 Athens, Greece.ORCID 0000-0001-8523-1024
Kaivon Pakzad-VaeziDepartment of Ophthalmology and Visual Sciences, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.
Jorge Ruiz-MedranoDepartment of Ophthalmology, Puerta de Hierro-Majadahonda University Hospital, Majadahonda, 28222 Madrid, Spain.
Bahram BodaghiDepartment of Ophthalmology, Pitié Salpêtrière University Hospital, Sorbonne Université, 75013 Paris, France.
Anat LoewensteinDepartment of Ophthalmology, Tel-Aviv Sourasky Medical Center Tel-Aviv, Israel Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel.ORCID 0000-0002-7706-1165
Jayakrishna AmbatiCenter for Advanced Vision Science, Department of Ophthalmology, Department of Pathology, Department of Microbiology, Immunology, and Cancer Biology, University of Virginia School of Medicine, Charlottesville, VA 22908, USA.
Marc D de SmetDepartment of Ophthalmology, University of Leiden, 2333 ZA Leiden, The Netherlands.
Ramin TadayoniDepartment of Ophthalmology, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010 Paris, France.
Sara TouhamiDepartment of Ophthalmology, Hôpital Lariboisière, Assistance Publique-Hôpitaux de Paris, Université de Paris, 75010 Paris, France.
Université Paris Cité · FRSorbonne Université · FRHospital Universitario Puerta de Hierro Majadahonda · ESLeiden University · NLNational and Kapodistrian University of Athens · GRTel Aviv University · ILUniversity of British Columbia · CAUniversity of Virginia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe study aimed to determine the outcomes and prognostic factors of vitrectomy, subretinal injection of tissue-plasminogen activator and gas tamponade in macular hemorrhage (MaH) due to age-related macular degeneration (AMD) or retinal arterial macroaneurysm (RAM).

methodsThe study design utilized a multicentric retrospective case series design of consecutive patients undergoing surgery between 2014 and 2019.

resultsA total of 65 eyes from 65 patients were included in the study. Surgery was performed after a mean period of 7.1 days. Displacement of MaH was achieved in 82% of the eyes. Mean best-corrected visual acuity (BCVA) improved from 20/500 to 20/125 at month(M)1 and M6 (

conclusionMaH surgery stabilizes or improves BCVA in 85% of cases. Younger age at diagnosis, better baseline BCVA figures, smaller subretinal MaH height and use of TE regime were predictive of the best postoperative outcomes.

Indexed as

age-related macular degenerationmacular hematomamacular hemorrhageprognosisretinal arterial macroaneurysmtreat and extendvitrectomy

Identifiers

PMID34945083
PMCPMC8703651
OpenAlexW4200014621

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.